ATE450549T1 - MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR FETAL ERYTHROID CELLS - Google Patents

MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR FETAL ERYTHROID CELLS

Info

Publication number
ATE450549T1
ATE450549T1 AT05736009T AT05736009T ATE450549T1 AT E450549 T1 ATE450549 T1 AT E450549T1 AT 05736009 T AT05736009 T AT 05736009T AT 05736009 T AT05736009 T AT 05736009T AT E450549 T1 ATE450549 T1 AT E450549T1
Authority
AT
Austria
Prior art keywords
specificity
cells
monoclonal antibodies
erythroid cells
fetal
Prior art date
Application number
AT05736009T
Other languages
German (de)
Inventor
Christiane Hollmann
Silke Zimmermann
Stefan Stachelhaus
Winfried Albert
Original Assignee
Adnagen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adnagen Ag filed Critical Adnagen Ag
Application granted granted Critical
Publication of ATE450549T1 publication Critical patent/ATE450549T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70582—CD71
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ecology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention concerns a monoclonal antibody and corresponding hybridoma cells and antigens suitable for isolating fetal cells from maternal blood. The inventive monoclonal antibody reacts with a surface antigen present on fetal red blood cells including their nucleated precursor cells, but not with surface antigens on adult erythroid cell.
AT05736009T 2004-03-31 2005-03-31 MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR FETAL ERYTHROID CELLS ATE450549T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04007811 2004-03-31
PCT/EP2005/003371 WO2005100401A2 (en) 2004-03-31 2005-03-31 Monoclonal antibodies with specificity for fetal erythroid cells

Publications (1)

Publication Number Publication Date
ATE450549T1 true ATE450549T1 (en) 2009-12-15

Family

ID=35150543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05736009T ATE450549T1 (en) 2004-03-31 2005-03-31 MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR FETAL ERYTHROID CELLS

Country Status (9)

Country Link
US (6) US7858757B2 (en)
EP (1) EP1732951B1 (en)
JP (1) JP4756032B2 (en)
AT (1) ATE450549T1 (en)
AU (1) AU2005233254B2 (en)
CA (1) CA2561830C (en)
DE (1) DE602005018028D1 (en)
ES (1) ES2337702T3 (en)
WO (1) WO2005100401A2 (en)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4756032B2 (en) * 2004-03-31 2011-08-24 アトナーゲン アクチエンゲゼルシャフト Monoclonal antibody with specificity for fetal red blood cells
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
DE102006062619B4 (en) * 2006-12-29 2012-04-26 Medion Diagnostics Ag Method for the determination of minor cell populations in heterogeneous cell populations
CN102171565B (en) 2008-08-04 2015-04-29 纳特拉公司 Methods for allele calling and ploidy calling
US20120185176A1 (en) 2009-09-30 2012-07-19 Natera, Inc. Methods for Non-Invasive Prenatal Ploidy Calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
EP2572003A4 (en) 2010-05-18 2016-01-13 Natera Inc METHODS OF CLASSIFYING NON-INVASIVE PRENATAL PLOIDY
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
AR084020A1 (en) 2010-11-30 2013-04-17 Genentech Inc ANTIBODIES FOR THE LOW AFFINITY HEMATOENCEPHALIC BARRIER RECEIVER AND ITS USES
WO2012088456A2 (en) 2010-12-22 2012-06-28 Natera, Inc. Methods for non-invasive prenatal paternity testing
AU2011358564B9 (en) 2011-02-09 2017-07-13 Natera, Inc Methods for non-invasive prenatal ploidy calling
US9174216B2 (en) 2013-03-13 2015-11-03 DeNovo Science, Inc. System for capturing and analyzing cells
US9404864B2 (en) 2013-03-13 2016-08-02 Denovo Sciences, Inc. System for imaging captured cells
EP2739587B1 (en) 2011-08-01 2020-05-27 Denovo Sciences Cell capture system
US10466160B2 (en) 2011-08-01 2019-11-05 Celsee Diagnostics, Inc. System and method for retrieving and analyzing particles
US20130122492A1 (en) * 2011-11-14 2013-05-16 Kellbenx Inc. Detection, isolation and analysis of rare cells in biological fluids
WO2013192620A1 (en) 2012-06-22 2013-12-27 Quantrx Biomedical Corporation Method for obtaining fetal cells and fetal cellular components
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US9752181B2 (en) 2013-01-26 2017-09-05 Denovo Sciences, Inc. System and method for capturing and analyzing cells
US9707562B2 (en) 2013-03-13 2017-07-18 Denovo Sciences, Inc. System for capturing and analyzing cells
US9856535B2 (en) 2013-05-31 2018-01-02 Denovo Sciences, Inc. System for isolating cells
US10391490B2 (en) 2013-05-31 2019-08-27 Celsee Diagnostics, Inc. System and method for isolating and analyzing cells
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US9499870B2 (en) 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
EP3957749A1 (en) 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
CN106488981A (en) * 2014-05-15 2017-03-08 科尔贝恩科斯公司 The preparation of the fetal nucleated red blood (NRBCS) for diagnostic test
US20160130553A1 (en) 2014-05-15 2016-05-12 Kellbenx Incorporated PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
WO2016021309A1 (en) * 2014-08-05 2016-02-11 富士フイルム株式会社 Method for separating nucleated red blood cells
US12202890B1 (en) 2014-11-07 2025-01-21 Kellbenx Incorporated Antibodies for detection and enrichment of fetal cells and their use
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
JP6234542B1 (en) 2016-12-27 2017-11-22 株式会社 TL Genomics Method for obtaining chromosomal DNA derived from fetal cells
US10894976B2 (en) 2017-02-21 2021-01-19 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
WO2019046307A1 (en) 2017-08-29 2019-03-07 Celsee Diagnostics, Inc. System and method for isolating and analyzing cells
US11666915B2 (en) 2017-10-19 2023-06-06 Tl Genomics Inc. Cell classification chip
JP2021506342A (en) 2017-12-14 2021-02-22 ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． Evaluation of Graft Conformity for Transplantation
US10946380B2 (en) * 2018-01-19 2021-03-16 International Business Machines Corporation Microfluidic chips for particle purification and fractionation
US12398389B2 (en) 2018-02-15 2025-08-26 Natera, Inc. Methods for isolating nucleic acids with size selection
CA3090426A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US10633693B1 (en) 2019-04-16 2020-04-28 Celsee Diagnostics, Inc. System and method for leakage control in a particle capture system
US20230258663A9 (en) 2019-05-02 2023-08-17 Kellbenx Incorporated Filtration-based methods for preparing fetal nucleated red blood cells (nrbcs) for diagnostic testing
EP3966307B1 (en) 2019-05-07 2024-11-20 Bio-Rad Laboratories, Inc. System and method for automated single cell processing
US11273439B2 (en) 2019-05-07 2022-03-15 Bio-Rad Laboratories, Inc. System and method for target material retrieval from microwells
EP3980559A1 (en) 2019-06-06 2022-04-13 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system
SG11202112898WA (en) 2019-06-14 2021-12-30 Bio Rad Laboratories System and method for automated single cell processing and analyses
US11504719B2 (en) 2020-03-12 2022-11-22 Bio-Rad Laboratories, Inc. System and method for receiving and delivering a fluid for sample processing
EP4396231A1 (en) 2021-09-01 2024-07-10 Biogen MA Inc. Anti-transferrin receptor antibodies and uses thereof
WO2023107539A1 (en) 2021-12-10 2023-06-15 Bio-Rad Laboratories, Inc. Compositions, methods, and systems for sample processing with morphology-adjustable functionalized particles
CN115861769B (en) * 2022-12-23 2026-02-03 正泰集团研发中心(上海)有限公司 Training method of plastic shell defect detection model, and plastic shell defect detection method and device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035433C2 (en) * 2000-07-20 2002-07-18 Tuma Wolfgang Gentle high enrichment of fetal cells from peripheral blood and use of the same
ITRM20010322A1 (en) 2001-06-08 2002-12-09 Consiglio Nazionale Ricerche NON-IVASIVE METHOD ON MATERNAL BLOOD FOR THE SCREENING AND DIAGNOSIS OF FETAL ANEUPLOIDIES.
JP4756032B2 (en) * 2004-03-31 2011-08-24 アトナーゲン アクチエンゲゼルシャフト Monoclonal antibody with specificity for fetal red blood cells

Also Published As

Publication number Publication date
US20160039932A1 (en) 2016-02-11
US20160084837A1 (en) 2016-03-24
US9453841B2 (en) 2016-09-27
CA2561830A1 (en) 2005-10-27
CA2561830C (en) 2013-05-21
DE602005018028D1 (en) 2010-01-14
AU2005233254B2 (en) 2011-11-24
EP1732951A2 (en) 2006-12-20
WO2005100401A2 (en) 2005-10-27
EP1732951B1 (en) 2009-12-02
US20110129916A1 (en) 2011-06-02
WO2005100401A3 (en) 2006-06-15
JP2007530629A (en) 2007-11-01
US20140154704A1 (en) 2014-06-05
US20230324383A1 (en) 2023-10-12
ES2337702T3 (en) 2010-04-28
US20070275418A1 (en) 2007-11-29
US8536312B2 (en) 2013-09-17
AU2005233254A1 (en) 2005-10-27
US7858757B2 (en) 2010-12-28
JP4756032B2 (en) 2011-08-24
US9194871B2 (en) 2015-11-24

Similar Documents

Publication Publication Date Title
ATE450549T1 (en) MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR FETAL ERYTHROID CELLS
ATE528648T1 (en) METHOD FOR DETECTING ANTIBODY PRODUCING CELLS
NZ623706A (en) Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
PT1308507E (en) ANTI-NUCLEUS HCV MONOCLONAL ANTIBODY
ATE468355T1 (en) DIABODY TYPE BISPECIFIC ANTIBODIES
MY171554A (en) Monoclonal antibody and immunoassay using the same
TW200616662A (en) Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates
EA200971114A1 (en) DETERMINATION OF ANTIGENS LOCATED ON ERYTHROCYTES AND ANTI-ERITROTSITAR ANTIBODIES
WO2008122793A3 (en) Blood group antibody screening
ATE464374T1 (en) ASSAY FOR THE RAPID DETECTION OF HUMAN ACTIVATED PROTEIN C AND HIGHLY SPECIFIC MONOCLONAL ANTIBODIES AGAINST IT
EP4527465A3 (en) Anti-glypican 3 antibodies
WO2008025964A3 (en) Antibodies to an epitope of agr2. assays and hybridomas
WO2004106385A3 (en) Monoclonal antibodies specific for buprenorphine and metabolites thereof
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
AU2003283240A8 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
WO2006020263A3 (en) Cytoxan antibodies and immunoassay
WO2006075142A3 (en) FORMS OF FACTOR XIIa
EP1879029A4 (en) A neuroglobin enzyme-linked immunodetection kit and the use of it
EP1359161A3 (en) Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof
WO2006044888A3 (en) Reagents for urine-based immunological assays
MX2022014580A (en) Double-multiplex assay for multiple immunoglobulin isotypes.
WO2007011698A3 (en) Humanized antibody conjugates and related methods, assays, reagents, and kits
WO2006005940A3 (en) Monoclonal anti-glut2 antibody
RU2005115525A (en) A Strain of Cultured Mouse Mouse Hybrid A3 Cells Used to Obtain Monoclonal Antibodies to Human Cell Nucleolus Antigen
BR0204612A (en) Hcv Antibody Monoclonal Antibodies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1732951

Country of ref document: EP